
#ãã€ãã¿ãŒãã¡ã€ã« 第ïŒïŒåŒŸïŒ ãè£œè¬æ¥çã¯ã©ã®ããã«ãœãŒã·ã£ã«ã¡ãã£ã¢ã«åããããã¯ã¯ãã³æ¿çã«é¢ããã³ã³ãã³ãã圢æããã®ãïŒã
ãã€ãã¿ãŒãã¡ã€ã«ç¬¬ïŒïŒåŒŸãå
¬éãããŸããã
ä»åã¯ããè£œè¬æ¥çã¯ã©ã®ããã«ãœãŒã·ã£ã«ã¡ãã£ã¢ã«åããããã¯ã¯ãã³æ¿çã«é¢ããã³ã³ãã³ãã圢æããã®ãïŒããšãããã®ã§ãã
ãŸãã¯å
šäœããŸãšããŸãã
ã»å€§æè£œè¬äŒç€Ÿã¯äžççãªå±æ©ãæå€§ã®ããžãã¹ãã£ã³ã¹ãšæããŠãã
ã»è£œè¬äŒç€Ÿã®ãããŒå£äœã¯ãä»ã®åœãäœäŸ¡æ Œã®ã¯ã¯ãã³ãäœãããšãåºæ¥ãªãããã«å¶è£ããããšãç±³åœæ¿åºã«èŠæ±ããŠãã
ã»è£œè¬äŒç€Ÿã®ãããŒæŽ»åã¯ããã€ãã¿ãŒã«ãåãã§ãã
ã»ãã€ãã¿ãŒã¯è£œè¬äŒç€Ÿãšãã€ãæ¿åºã®èŠè«ã«å¿ããŠããªã³ã©ã€ã³ãã£ã³ããŒã³ïŒãã€ãã¿ãŒãã¢ïŒã匟å§ããŠãã
ã»è£œè¬äŒç€Ÿã®ãããŒå£äœãåºè³ããèšè«çµ±å¶è«è² æ¥è ã®PGPã¯ãã¯ã¯ãã³ãã¹ããŒããåŒ·å¶æ¥çš®ãžã®ç念ãªã©ãèŠå¶ããŠãã
ã»PGPã®èšè«çµ±å¶ã¯ã補è¬äŒç€Ÿã«ã¯é©çšãããªãã£ã
ãã¡ãã§ãçŸåšå ¬éãããŠããå šãŠã®ãã€ãã¿ãŒãã¡ã€ã«ãå®å šç¿»èš³ããŠããŸãã
éå»ã®èšäºããŸã ãèªã¿ã§ãªãæ¹ã¯ããŸãã¯ãã¡ãããã©ããã
ããã§ã¯ãæ©é翻蚳ããŠãããŸãã
ã¯ããã«
ïŒç¿»èš³ããããïŒ
1. New piece from the TWITTER FILES.
â Lee Fang (@lhfang) January 16, 2023
How the pharmaceutical industry lobbied social media to shape content around vaccine policy.
The push included direct pressure from Pfizer partner BioNTech to censor activists demanding low-cost generic vaccines for low-income countries.
ãã€ãã¿ãŒã»ãã¡ã€ã«ããã®æ°äœã
ãè£œè¬æ¥çã¯ã©ã®ããã«ãœãŒã·ã£ã«ã¡ãã£ã¢ã«åããããã¯ã¯ãã³æ¿çã«é¢ããã³ã³ãã³ãã圢æããã®ãïŒã
ãã®äžã«ã¯ããã¡ã€ã¶ãŒã®ããŒãããŒã§ãããã€ãªããã¯ç€ŸããäœæåŸåœåãã®äœäŸ¡æ Œãªãžã§ããªãã¯ã¯ã¯ãã³ãèŠæ±ããæŽ»åå®¶ãæ€é²ããããçŽæ¥å§åããããŠããããšãå«ãŸããŠããŸãã
倧æè£œè¬äŒç€Ÿã¯äžççãªå±æ©ãæå€§ã®ããžãã¹ãã£ã³ã¹ãšæããŠãã
2020幎ããã³ãããã¯ã«ã¯è¿ éãªæè¡é©æ°ãå¿ èŠã§ããããšãæããã«ãªããŸããã
ãã®å±æ©ãè¿
éã«è§£æ±ºããããã«ãã¢ã€ãã¢ãæè¡ãæ°ãã圢ã®å»çãå
±æããããã®åœéçãªããŒãããŒã·ãããæ§ç¯ããããšããæ©ãããæ±ããããŠããŸããã
C-TAPã®äžã§ã®æ°ããåå®ã¯ãã³ããæ€æ»æè¡ãžã®äžççãªã¢ã¯ã»ã¹ãæ¹åããããšãç®æã
MPPãžã¥ããŒã - C-TAPã代衚ããå»è¬åç¹èš±ããŒã«ïŒMPPïŒãšåã¢ããªã«ã®è£œè¬äŒç€Ÿãã€ãªããã¯ã»ã¢ããªã«ãšã®éã§ç· çµãããæ°ããããªãŒãã³ã§éææ§ã®é«ããµãã©ã€ã»ã³ã¹å¥çŽã«ãããã³ããæ€æ»æè¡ã®è£œé ãå éãããããšã«ãªããŸããã
ããããäžçã®å·šå€§è£œè¬äŒæ¥ã¯ããã®å±æ©ããã€ãŠãªãã»ã©ã®å©çãçããã£ã³ã¹ãšãšãããæ²»çè¬ãã¯ã¯ãã³ãå«ãæ°ããã³ããé¢é£å»è¬åã®ç¹èš±ãIPãå ±æããããã®ããããåªåãã€ã¶ãããšãå¯å®€ã§å€§èŠæš¡ãªãããŒæŽ»åãéå§ããã®ã§ãã
補è¬äŒç€Ÿã®ãããŒå£äœã¯ãä»ã®åœãäœäŸ¡æ Œã®ã¯ã¯ãã³ãäœãããšãåºæ¥ãªãããã«å¶è£ããããšãç±³åœæ¿åºã«èŠæ±ãã
ã¢ãã«ããšãã¡ã€ã¶ãŒãå«ããã€ãªè£œè¬äŒç€Ÿã代衚ãããããŒå£äœã§ãããBIOãã¯ãæ°ããéžã°ãããã€ãã³æ¿æš©ã«æçŽãæžããç¹èš±æš©ã䟵害ããäœã³ã¹ãã®ã³ããè¬ãã¯ã¯ãã³ã®åŸçºåãäœãããšããåœãç±³åœæ¿åºãå¶è£ããããã«èŠæ±ããŸããã
å»è¬åããã€ã¹ãã¯ãäœäŸ¡æ Œã®ã¯ã¯ãã³ãæšé²ããå€åœã眰ããããã«ãã€ãã³ãèŠæ±ããã
倧æè£œè¬äŒç€Ÿã¯ãã³ããã®ã¯ã¯ãã³çç£ãå³ãã管çããäžçäžã§å ¥æå¯èœãªãã®ãå¶éããäžæ¹ã§ãäœååãã®å©çãåŸãããã«æŠã£ãŠããŸãã
補è¬äŒç€Ÿã®ãããŒæŽ»åã¯ããã€ãã¿ãŒã«ãåãã§ãã
ããã«ããã€ãã¿ãŒãé¢ãã£ãŠããŸãã
äžççãªãããŒæŽ»åã«ã¯ããœãŒã·ã£ã«ã¡ãã£ã¢ãžã®çŽæ¥çãªå§åãå«ãŸããŠããŸããã
ãã¡ã€ã¶ãŒã®ã¯ã¯ãã³ãéçºãããã€ãªã³ããã¯ã¯ããã€ãã¿ãŒã«é£çµ¡ãã€ããŠããžã§ããªãã¯ã®äœäŸ¡æ Œã¯ã¯ãã³ãæ±ãããŠãŒã¶ãŒã®ãã€ãŒããçŽæ¥æ€é²ããããã«èŠè«ããŸããã

ã¢ã«ã·ã¥ãã€ã¶ãŒæ§
BSIã¯ã2020.12.11ïŒéïŒã®å€ãImpfsloffã¡ãŒã«ãŒã«å¯ŸããŠãªã³ã©ã€ã³ãã£ã³ããŒã³ãè¡ããããšããæ å ±ãåŸãŸããã
æ¥ããæææ¥ã® 2020.12.14ã«ã掻åå®¶ã¯ãå ¬æ£ãªã³ããã¯ã¯ãã³é åžãã®åã®äžã«ãªã³ã©ã€ã³ãã£ã³ããŒã³ãè¡ãããšãåŒã³ãããŠããŸãã
ãªã³ã©ã€ã³ãã£ã³ããŒã³ã§ã¯ããœãŒã·ã£ã«ã¡ãã£ã¢ãéããŠãã€ãªã³ããã¯ãåœç€Ÿåç· åœ¹ã«çŽæ¥é£çµ¡ããããåŒã³ãããŠããŸãã
æ¥ææ¥ãã2æ¥éããã€ãªã³ããã¯ã®ãã€ãã¿ãŒã¢ã«ãŠã³ãããé衚瀺ãã«ããŠãã³ã¡ã³ããªã©ãã§ããªãããã«ããããšã«ããååããã ããªãã§ããããã
ãããããé¡ãããŸãã
ãžã£ã¹ãã³ã»ã¢ã©ããŽã£ãã
ãã€ãã¿ãŒã¯è£œè¬äŒç€Ÿãšãã€ãæ¿åºã®èŠè«ã«å¿ããŠããªã³ã©ã€ã³ãã£ã³ããŒã³ïŒãã€ãã¿ãŒãã¢ïŒã匟å§ããŠãã
ãã€ãã¿ãŒã®æ åœè ã¯ããã€ãæ¿åºãåŸæŒããã補è¬äŒç€Ÿã®èŠè«ã«è¿ éã«å¯Ÿå¿ããŸããã
ãšãŒãããã®ããã€ã¹ãã¯ããã¡ã€ã¶ãŒãã¢ã¹ãã©ãŒãã«ããããŠãPeoplesVaccineãïŒäººã ã®ããã®ã¯ã¯ãã³ïŒã®ãããªæŽ»åå®¶ã®ããã·ã¥ã¿ã°ã®ã¢ã«ãŠã³ããç£èŠããããã«ã³ã³ãã³ãèŠå¶ããŒã ã«äŸé ŒããŸããã

ããã»ã¢ã«ã·ã¥ããŠã¶ãŒ
é¡ïŒGET&SIã®ãµããŒãããé¡ãããŸãããã€ãªã³ããã¯ããã¡ã€ã¶ãŒãã¢ã¹ãã©ãŒãã«ã察象ãšãããã£ã³ããŒã³ã12æ14æ¥ã«çºè¡š
å®å GETSupportãSite Integrityãip-crewãCc:
TwSãããSIãããLPãããããã«ã¡ã¯ã
(+NickãšKatyã¯ããããã®ããŒã±ããã«é¢é£ãããã)
ç§ãã¡ã¯ãã€ãªã³ããã¯ãšãã€ãé£éŠæ å ±ã»ãã¥ãªãã£å±ãããã³ããã¯ã¯ãã³ãéçºããŠãã補è¬äŒç€Ÿã察象ãšãããªã³ã©ã€ã³ãã£ã³ããŒã³ãææ¥ã12æ14æ¥ïŒæïŒåå9æïŒäžå€®ãšãŒãããæéïŒããéå§ããããšé£çµ¡ãåããŸããã
äºæ³ãããããã·ã¥ã¿ã°ã¯ä»¥äžã®éãã§ãã
#JoinCTAP ããã³
#PeoplesVaccine
é¢é£ããããã·ã¥ã¿ã°ãšä»¥äžã®ã¢ã«ãŠã³ãã«ã泚ç®ããã ããç§ãã¡ããµããŒãããŠããã ããŸãããïŒ
@bioNTech_Group
@pfizer
@pfizer_de
@moderna_tx
@AstraZeneca
åœå±ã¯ããã®è¡çºã«ãããæ·±å»ãªçµæãã«ã€ããŠèŠåããŠããŸãã
ããªãã¡ãããã€ãã¿ãŒã®å©çšèŠçŽïŒTOSïŒã«éåããå¯èœæ§ã®ãããæçš¿ãã³ã¡ã³ããæº¢ããããŠãŒã¶ãŒã¢ã«ãŠã³ããä¹ã£åããããããšãäºæ³ãããŠããŸãã
ç¹ã«ãã¯ã¯ãã³ã¡ãŒã«ãŒã®å人ã¢ã«ãŠã³ããã¿ãŒã²ããã«ãªããšèšãããŠããŸãã
ããã«äŒŽããåœã¢ã«ãŠã³ããäœæãããå¯èœæ§ããããŸãã
ãã€ãåœå±ã¯ãç¹ã«ãœãŒã¹ã«ãèšåããŠããŸãã
ïŒèªåæçš¿ããããã€ãŒããèš±ããããã£ã³ããŒã³ã§ããïŒ
ãäžæãªç¹ããããŸãããããç¥ãããã ããã
ããããšãããããŸããã
ãã
å®äŸ¡ãªã¯ã¯ãã³ãæã人ãã¡ãèšè«çµ±å¶ãããŠãã
ãã€ãã¿ãŒã§ãã¡ã€ã¶ãŒã«æè°ããããã«ç£èŠããŠãããåœã¢ã«ãŠã³ããã®å¯èœæ§ïŒ
ãããã¯å®åšã®äººç©ã§ããã
ãã€ãã¿ãŒããŒã ãå©çšèŠçŽéåã®å¯èœæ§ããããšããŠãã©ã°ãç«ãŠããã®ããã¡ãã§ãã
ç§ã¯ãã€ã®ãªã¹ã®74æ³ã®åŒéããã¬ã³ã¬è·äººãããªãŒãšé»è©±ã§è©±ããŸããã
Dear @AlbertBourla, @sbancel & #PascalSoriot, 9/10 people in poor countries are going to MISS OUT on a #COVID19 vaccine next year. Will @Pfizer, @BioNTech_Group @moderna_tx & @AstraZeneca #JoinCTAP to ensure that everyone, everywhere can be safe? We need a #PeoplesVaccine!
â Terry Brough #PeaceJusticeSocialism â (@TerryB28937065) December 14, 2020
芪æãªã@AlbertBourlaã@sbancelã#PascalSoriotã
è²§ããåœã®å人äžã®ä¹äººã¯ãæ¥å¹Žã³ããã¯ã¯ãã³ãæã«å ¥ããããšãã§ããªããªãããã§ãã
ãã¡ã€ã¶ãŒããã€ãªã³ããã¯ã°ã«ãŒããã¢ãããã¢ã¹ãã©ãŒãã«ãCTAPã«åå ããã°ã誰ãããã©ãã§ããå®å šã«æ¥çš®ã§ããããã«ãªãã®ã§ããããïŒ
ç§ãã¡ã¯ 人ã ã®ããã®ã¯ã¯ãã³ãå¿ èŠãšããŠããã®ã§ãã
ãã®ç¹å¥ãªèŠæ±ã«å¯ŸããŠããã€ãã¿ãŒç€Ÿãæçµçã«ã©ã®ãããªè¡åããšã£ããã¯äžæã§ãã
ãã€ãã¿ãŒã®è€æ°ã®ç€Ÿå¡ããã®åŸã®ã¡ãã»ãŒãžã§ããã®æŽ»åã¯ã©ããäžæ£äœ¿çšã«ã¯åœãããªããšææããŠããŸãã
ããããå瀟ã¯ãã€ãŒãã®ç£èŠãç¶ããŠããŸããã
補è¬äŒç€Ÿã®ãããŒå£äœãåºè³ããèšè«çµ±å¶è«è² æ¥è ã®PGPã®æŽ»å
å¥ã®åããšããŠããã¡ã€ã¶ãŒãšã¢ãã«ãã®ãããŒå£äœã§ããBIOã¯ããããªãã¯ã»ã°ããã»ãããžã§ã¯ãïŒPGPïŒãšããè«è² æ¥è
ãäŒç»ããç¹å¥ãªã³ã³ãã³ãèŠå¶ãã£ã³ããŒã³ã«å
šé¡åºè³ãããã€ãã¿ãŒãšååããŠããèª€å ±ãã«ã€ããŠã®ã³ã³ãã³ãèŠå¶ã«ãŒã«ãèšå®ããŸããã
BIOã¯ãã®ãã£ã³ããŒã³ã«127äž5000ãã«ãæäŸãããã®äžéšã¯çŽçšç³åæžãéããŠæããã«ãããŠããŸãã
PGPãã£ã³ããŒã³ã¯ãéç§°ãã¹ããã³ã¬ãŒããšåŒã°ãããã€ãã¿ãŒã®ã³ã³ãã³ãèŠå¶ãããã®äœæãæ€èšŒãåããå ¬å ±ãã«ã¹ã¢ã«ãŠã³ãã®éžæãã³ã³ãã³ãã®åé€ãé éããæ¯æŽããŸããã

ã»ã¯ã·ã§ã³ B. ç¬ç«è«è² 人
1 çµç¹ãã 10 äžãã«ä»¥äžã®å ±é ¬ãåãåã£ããæãå ±é ¬ã®é«ãç¬ç«è«è² 人 5 人ã«ã€ããŠããã®è¡šã«èšå ¥ããŠãã ããã
çµç¹ã®èª²çšå¹ŽåºŠæ«ãŸãã¯å¹ŽåºŠå ã®æŠå¹Žã®å ±é ¬ãå ±åããŠãã ããã

ã¢ã«ãŠã³ããå ±åããæ¹æ³
èª€å ±ãšããŠå ±åãã
èª€å ±ã¯èŠãã°ããããŸãã
ãã®æçš¿ãé©åãªãã©ãããã©ãŒã ã«å ±åããŠãä»ã®èª°ã«ãèŠããªãããã«ããŸãããã
ã¢ã«ãŠã³ããå ±åãããšãã¯ãç§å¯è£ã«è¡ãããŸãã
BIOãè³éæäŸãããã£ã³ããŒã³ã泚ç®ãããã€ãŒãã®å€ãã¯ãã¯ã¯ãã³ã«ãã€ã¯ãããããå«ãŸããŠãããšãã䞻匵ã®ãããªãæ¬åœã«åæºããŠãã誀æ
å ±ã§ããã
ãããããã¹ããã³ã¬ãŒãããã€ãã¿ãŒã«åããããä»ã®ãã®ã¯ãã¯ã¯ãã³ãã¹ããŒããã¯ã¯ãã³åŒ·å¶æ¥çš®ã®ãããªãããã°ã¬ãŒãªé åã§ããã

ã¯ã¯ãã³çŸ©ååã«ã€ããŠç¥ã£ãŠããã¹ãããš
ãã€ãã³å€§çµ±é ã®æ°ããã³ããæŠç¥ã¯ãç±³åœã®åŽåè ã®3åã®2ã«åœ±é¿ãäžããã
ãã€ãã³å€§çµ±é ã¯å é±ãã³ããã«å¯Ÿæãããã³ãããã¯ã®æµããå€ããããã®6é ç®ã®æŠç¥ãçºè¡šããŸããã
ãã®èšç»ã¯ãç±³åœã®åŽåè ã®3åã®2ã«åœ±é¿ãäžãããã®ã§ããããŸã§ã§æãå æ¬çãªã¯ã¯ãã³æ¥çš®ã®çŸ©åä»ããšãªããã®ã§ãã

ã¹ããã¡ããŒã»ã»ãã
ãã¯ã¯ãã³æ¥çš®è ãšæªæ¥çš®è ããç¹ã«ãã«ã¿åã®ãŠã€ã«ã¹ãéã³ãæåºããææãããèœåãã»ãŒåãã ãšããããã¯ã¯ãã³æ¥çš®ãã¹ããŒãã宿œããããšã¯ããŠã€ã«ã¹ã®æ¡æ£ã«å®éã«ã©ããªéããããããã®ãïŒã
 zerohedge.com/geopolitical/s...
ã¢ãã«ããšãã¡ã€ã¶ãŒãè³éæäŸãããã£ã³ããŒã³ã§ã¯ãåé€ãããã€ãŒããšæ€èšŒããä»ã®ãã€ãŒãã®ãªã¹ããèšèŒããããã€ã¬ã¯ããªå®æã¡ãŒã«ãéã£ãŠããŸããã
ããã¯ããã€ãã¿ãŒã®ããã€ã¹ããã³ã³ãã³ãèŠå¶è ã«çŽæ¥éãããããã®çš®ã®ã¡ãŒã«ã®äžäŸã§ãã
å€ãã¯ã忢ããã@zerohedgeã«çŠç¹ãåœãŠããã®ã§ãã

é¡ïŒPGPèª€å ±å ±åã»æ€èšŒäŸé Œæž
çããããã«ã¡ã¯ã
ä»é±ã®èª€å ±ã¬ããŒããšäžæ¬æ€èšŒã®äŸé Œãæ·»ä»ããŸãã
ã» ã¯ã¯ãã³ã«å察ãã人ã ã¯ãCDCãã¯ã¯ãã³æ å ±ãé ããŠãããšããNYã¿ã€ã ã¹ã®èšäºã«åºã¥ããŠããŸãã
ãã®èšäºèªäœã«ã¯èª€ã£ãæ å ±ã¯å«ãŸããŠããŸããããCDCãä¿¡é Œã§ããªãããšãããã«èšŒæããããã«ããã®ãã¥ãŒã¹ãå©çšããŠããŸãã
ã»ããäžã€ã®å€§ããªãã¬ã³ãèšäºã¯ããã€ãã®å¥åº·ä¿éºäŒç€Ÿã®è·å¡ããã¯ã¯ãã³ã®å¯äœçšã«ããå»çæ©é¢ãžã®èšªåã®å ±åã¯ãæå®³äºè±¡ã®å ¬åŒå ±åãšäžèŽãããå ¬åŒå ±åã¯ã²ã©ãéå°è©äŸ¡ãããŠãããããããªããšè¿°ã¹ãŠããããšã«ã€ããŠè©³ããæžãããŠããŸãã
ãã®èšäºã¯ããã®ããŒã¿ã«ã¯ããããå¯äœçšãå«ãŸããŠããããšã«çæããŠãããããäºå®ç¢ºèªãå°é£ã§ãã
äœã質åãããã°ããç¥ãããã ããã
ããããšãããããŸããã
PGPã®èšè«çµ±å¶ã¯ã補è¬äŒç€Ÿã«ã¯é©çšãããªãã£ã
泚ç®ãã¹ãã¯ããã®ãããªæ€é²ãã©ãã«ä»ããè¡ãå€§èŠæš¡ãªè¡åãã補è¬äŒç€Ÿã«ã¯é©çšãããªãã£ãããšã§ãã
倧æè£œè¬äŒç€ŸãäœäŸ¡æ Œã®ã³ããã¯ã¯ãã³ã®ãžã§ããªãã¯ãäœããªã¹ã¯ãä¹±æŽã«èªåŒµãããšããã¹ããã³ã¬ãŒã¯äœãããŸããã§ããã
ãã®ã«ãŒã«ã¯ç£æ¥çã®æ¹è©å®¶ã«ã®ã¿é©çšãããã®ã§ãã
The biopharma sector employs more than 900,000 workers and supports 4.4 million U.S. jobs. Those jobs would be at risk if the #TRIPS waiver is extended to #COVID19 treatments. Read more about the real consequences of waiving commitments to protect IP: https://t.co/0ppR9AUQGl
â PhRMA (@PhRMA) November 9, 2022
PhRMA
ããã€ãªè£œè¬éšéã¯90äžäººä»¥äžãéçšããç±³åœã®440äžäººã®éçšãæ¯ããŠããã
ãã#TRIPSã®å é€ãã³ããã®æ²»çã«æ¡å€§ãããã°ããããã®éçšãå±éºã«ãããããããšã«ãªãã
ç¥ç財ç£ãä¿è·ããããã®å ¬çŽãæŸæ£ããããšã®æ¬åœã®çµæã«ã€ããŠãã£ãšèªããã
åŒçšèšäºïŒãWTOã®ç¥çè²¡ç£æš©æŸæ£ã®æ¡å€§ã¯ã¢ã¡ãªã«ãèŠãããã
ç±³åœãæå 端ã®ã³ããæ²»çæ³ãéçºããã®ã¯å¶ç¶ã§ã¯ãããŸãããã
ãã¡ãã¯ç§ã®å ±åããèšäºã§ããã詳现ãªãã®ã§ãã
ã³ãã補è¬äŒç€Ÿã¯ããžã§ããªãã¯ã¯ã¯ãã³ãæšé²ããæŽ»åå®¶ãæ€é²ããããã«ãã€ãã¿ãŒã«å§åããããŸããã
ãã®ãœãŒã·ã£ã«ã¡ãã£ã¢äžã®å§åãã£ã³ããŒã³ã¯ãç¹èš±ãä¿æããèšé²çãªå©çãäžããããã«è£œè¬æ¥çãæåãããããŒæŽ»åã®äžç°ã«éããªãã
ç§ã¯ãã€ãã¿ãŒã®ã¡ãŒã«ã«ã¢ã¯ã»ã¹ããããšãèš±ãããŸããã
ç§ã¯äœã眲å/åæããŠãããããã€ãã¿ãŒã¯ç§ãè¡ã£ãããšãæžããããšã«äœã®åœ±é¿ãäžããŠããŸããã
æ€çŽ¢ã¯ãã€ãã¿ãŒã®åŒè·å£«ã«ãã£ãŠè¡ãããã®ã§ãç§ãèŠããã®ã¯éå®çãããããŸããã
ãŸãã@mtaibbiã@ShellenbergerMDã@bariweiss/@TheFPãªã©ã«ãããã€ãã¿ãŒã®ã¬ããŒãããæ¥œãã¿ã«ã
ãµãã¹ã¿ãã¯ã§ç§ãèŠã€ããã«ã¯ããããã¯ãªãã¯ããŠãã ããã
ïŒç¿»èš³ãããŸã§ïŒ
ãããã§ããã§ããããïŒ
ä»åã®èšäºã§ã¯ã補è¬äŒç€Ÿã®ãããŒå£äœãæ¿åºããã€ãã¿ãŒã«åããããŠãæãã®ãŸãŸã«èšè«çµ±å¶ããæ§ãæŽé²ãããŠããŸãã
泚ç®ãã¹ãã¯èšè«çµ±å¶å°éã®è«è² æ¥è
ã«åºè³ããŠãäžè«ã圢æããããšããŠããç¹ã§ããããã
éã«ç¬¬äžè ãä»ããããšã§ããããããªæ³çèŠå¶ãæ»ãæœãããšãã§ããã®ãããããŸããã
ããã§èŠå¶ãããŠããã®ã¯ãã¯ã¯ãã³å察è«è
ã ãã§ã¯ãªããŠãã¯ã¯ãã³ãå®ãäŸçµŠããŠãããšäŸé Œãããã¯ã¯ãã³æšå¥šæŽŸã®èšè«ãèŠå¶ãããŠããç¹ã§ãã
ãã®äºå®ã ããéã¿ãŠãã補è¬äŒç€Ÿã®å»ºåã§ãããå¥åº·ã®ããã«ã¯ã¯ãã³ãæšå¥šããããšãã£ãèšèã厩ãå»ã£ãŠãããŸãã
ãã®è©±é¡ã¯éåžžã«å€§ããªè«ç¹ã ãã«ããŸã ãŸã æéããããŠæ°ã ã®ãã€ãã¿ãŒãã¡ã€ã«ã§æŽé²ãããŠããããšãšæããŸãã
ãã¡ãã®ãã¬ãžã³ã«ç»é²ããŠãææ°èšäºããåŸ ã¡ãã ããã
#TwitterFiles #Twitter #Twitterãã¡ã€ã« #ãã€ãã¿ãŒãã¡ã€ã« #ãã€ãã¿ãŒ
#LeeFang